Southeast AIDS Education and Training Center (SE AETC) | 615-875-7873

Webinar: HIV/HCV Coinfection: Why It Matters and What To Do About It

Primary Care & Comorbidities, Webcast

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides

Facilitated by Cody A. Chastain, MD
October 26, 2016

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides

Facilitated by Cody A. Chastain, MD
October 26, 2016

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presentation

Slides